U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
Trump Appoints Colin McDonald as Assistant Attorney General for National Fraud Enforcement
UAE Plans Temporary Housing Complex for Displaced Palestinians in Southern Gaza
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
NATO to Discuss Strengthening Greenland Security Amid Arctic Tensions
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Faith Leaders Arrested on Capitol Hill During Protest Against Trump Immigration Policies and ICE Funding
Pentagon Ends Military Education Programs With Harvard University
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 



